Which of the following represents the proper order of steps in the standard drug development process for a new medication without special drug designation (e.g., Fast Track, Accelerated Approval)?
A. Discovery and development > FDA review of NDA > preclinical research > clinical research > FDA approval > post-marketing drug safety monitoring
B. Discovery and development > preclinical research > clinical research > FDA approval > post-marketing drug safety monitoring > FDA review of NDA
C. Discovery and development > preclinical research > clinical research > FDA review of NDA > FDA approval > post-marketing drug safety monitoring
D. Discovery and development > preclinical research > FDA review of NDA > FDA approval > post-marketing drug safety monitoring > clinical research